Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.368,02
0,05%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Conatus Pharmaceuticals Inc (CNAT) Conatus Pharmaceuticals Inc (CNAT) Notizie

CNAT

Conatus Pharmaceuticals (CNAT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNAT
DataOraFonteTitoloSimboloCompagnia
05/06/202022:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202022:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202022:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202022:11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202014:00GlobeNewswire Inc.Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Hist...NASDAQ:CNATConatus Pharmaceuticals Inc
14/05/202014:00GlobeNewswire Inc.Histogen Publishes Preclinical Data on its HST 004 Spinal Disc ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
11/05/202014:00GlobeNewswire Inc.Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic AlopeciaNASDAQ:CNATConatus Pharmaceuticals Inc
07/05/202022:05GlobeNewswire Inc.The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reco...NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202022:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202022:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
20/04/202014:00GlobeNewswire Inc.Histogen Announces Investigational Device Exemption Application for HST 002NASDAQ:CNATConatus Pharmaceuticals Inc
15/04/202014:00GlobeNewswire Inc.Histogen Publishes New Preclinical Data on its HST 003 Orthopedic ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
06/04/202014:00GlobeNewswire Inc.Histogen Announces Investigational New Drug Application Amendment for HST 001NASDAQ:CNATConatus Pharmaceuticals Inc
02/04/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNATConatus Pharmaceuticals Inc
01/04/202022:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNATConatus Pharmaceuticals Inc
30/03/202023:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202022:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202021:45GlobeNewswire Inc.Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
07/02/202023:09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:CNATConatus Pharmaceuticals Inc
06/02/202014:00PR Newswire (US)Histogen to Present at BIO CEO & Investor ConferenceNASDAQ:CNATConatus Pharmaceuticals Inc
05/02/202020:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNATConatus Pharmaceuticals Inc
30/01/202014:00PR Newswire (US)Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care PartnershipNASDAQ:CNATConatus Pharmaceuticals Inc
28/01/202022:05GlobeNewswire Inc.Conatus Pharmaceuticals and Histogen Enter into Definitive Merger AgreementNASDAQ:CNATConatus Pharmaceuticals Inc
18/11/201922:05GlobeNewswire Inc.Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board MemberNASDAQ:CNATConatus Pharmaceuticals Inc
05/11/201922:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Third Quarter 2019 Financial ResultsNASDAQ:CNATConatus Pharmaceuticals Inc
06/08/201922:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Second Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201922:06GlobeNewswire Inc.Conatus to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201922:05GlobeNewswire Inc.Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH CirrhosisNASDAQ:CNATConatus Pharmaceuticals Inc
02/05/201922:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
30/04/201913:30GlobeNewswire Inc.Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver St...NASDAQ:CNATConatus Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNAT

La tua Cronologia

BIT
P1HZM8
BNP Paribas Issuance
USOTC
ELBDF
Elbit Medical Technologies (GM)
BIT
P1BVS7
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network